Octreotide prolonged-release (Ambrilia Biopharma)
奥曲肽缓释剂 （Ambrilia Biopharma）
Report date: 2024/03/28 20:00:34
Base Information
Drug NameOctreotide prolonged-release (Ambrilia Biopharma)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[7]
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAmbrilia Biopharma Inc
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesAmbrilia Biopharma Inc
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A